0.22 USD
+0 (+1.95%)
Taking everything into account, ZJYL scores 4 out of 10 in our fundamental rating. ZJYL was compared to 186 industry peers in the Health Care Equipment & Supplies industry. ZJYL has an average financial health and profitability rating. ZJYL is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
In the past year ZJYL was profitable.
In the past year ZJYL had a positive cash flow from operations.
In the past 5 years ZJYL has always been profitable.
Of the past 5 years ZJYL 4 years had a positive operating cash flow.
1.2 Ratios
ZJYL has a better Return On Assets (3.69%) than 79.57% of its industry peers.
The Return On Equity of ZJYL (6.42%) is better than 80.11% of its industry peers.
ZJYL has a better Return On Invested Capital (3.84%) than 72.58% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ZJYL is in line with the industry average of 8.84%.
The last Return On Invested Capital (3.84%) for ZJYL is well below the 3 year average (9.49%), which needs to be investigated, but indicates that ZJYL had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.69% | ||
| ROE | 6.42% | ||
| ROIC | 3.84% |
ROA(3y)9.9%
ROA(5y)10.46%
ROE(3y)14.18%
ROE(5y)16.34%
ROIC(3y)9.49%
ROIC(5y)11.9%
1.3 Margins
Looking at the Profit Margin, with a value of 7.85%, ZJYL belongs to the top of the industry, outperforming 80.11% of the companies in the same industry.
In the last couple of years the Profit Margin of ZJYL has declined.
ZJYL has a Operating Margin of 8.57%. This is in the better half of the industry: ZJYL outperforms 77.42% of its industry peers.
ZJYL's Operating Margin has declined in the last couple of years.
The Gross Margin of ZJYL (35.79%) is worse than 71.51% of its industry peers.
In the last couple of years the Gross Margin of ZJYL has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.57% | ||
| PM (TTM) | 7.85% | ||
| GM | 35.79% |
OM growth 3Y6.9%
OM growth 5Y-6.46%
PM growth 3Y7.26%
PM growth 5Y-2.67%
GM growth 3Y9.69%
GM growth 5Y1.86%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ZJYL is creating some value.
The number of shares outstanding for ZJYL has been increased compared to 1 year ago.
Compared to 5 years ago, ZJYL has less shares outstanding
ZJYL has a worse debt/assets ratio than last year.
2.2 Solvency
ZJYL has an Altman-Z score of 2.83. This is not the best score and indicates that ZJYL is in the grey zone with still only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.83, ZJYL is doing good in the industry, outperforming 70.97% of the companies in the same industry.
ZJYL has a Debt/Equity ratio of 0.56. This is a neutral value indicating ZJYL is somewhat dependend on debt financing.
ZJYL has a Debt to Equity ratio of 0.56. This is in the lower half of the industry: ZJYL underperforms 60.22% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.56 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 2.83 |
ROIC/WACC0.58
WACC6.65%
2.3 Liquidity
A Current Ratio of 2.11 indicates that ZJYL has no problem at all paying its short term obligations.
The Current ratio of ZJYL (2.11) is comparable to the rest of the industry.
ZJYL has a Quick Ratio of 1.90. This is a normal value and indicates that ZJYL is financially healthy and should not expect problems in meeting its short term obligations.
ZJYL has a Quick ratio (1.90) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.11 | ||
| Quick Ratio | 1.9 |
3. Growth
3.1 Past
The earnings per share for ZJYL have decreased strongly by -39.04% in the last year.
Measured over the past 5 years, ZJYL shows a small growth in Earnings Per Share. The EPS has been growing by 3.28% on average per year.
ZJYL shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.42%.
ZJYL shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.90% yearly.
EPS 1Y (TTM)-39.04%
EPS 3Y5.52%
EPS 5Y3.28%
EPS Q2Q%-105.22%
Revenue 1Y (TTM)13.42%
Revenue growth 3Y4.22%
Revenue growth 5Y2.9%
Sales Q2Q%-6.4%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
ZJYL is valuated rather expensively with a Price/Earnings ratio of 22.00.
ZJYL's Price/Earnings ratio is rather cheap when compared to the industry. ZJYL is cheaper than 80.65% of the companies in the same industry.
ZJYL is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 26.51, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 22 | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | -7.41 |
4.3 Compensation for Growth
ZJYL has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)6.71
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for ZJYL!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NASDAQ:ZJYL (12/31/2025, 8:00:02 PM)
0.22
+0 (+1.95%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners0.14%
Inst Owner Change-66.97%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap34.44M
Revenue(TTM)22.83M
Net Income(TTM)1.79M
AnalystsN/A
Price TargetN/A
Short Float %0.58%
Short Ratio0.17
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 22 | ||
| Fwd PE | N/A | ||
| P/S | 1.51 | ||
| P/FCF | N/A | ||
| P/OCF | 26.4 | ||
| P/B | 1.23 | ||
| P/tB | 1.28 | ||
| EV/EBITDA | -7.41 |
EPS(TTM)0.01
EY4.55%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)0.01
OCFY3.79%
SpS0.15
BVpS0.18
TBVpS0.17
PEG (NY)N/A
PEG (5Y)6.71
Graham Number0.2
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.69% | ||
| ROE | 6.42% | ||
| ROCE | 7.04% | ||
| ROIC | 3.84% | ||
| ROICexc | 13.32% | ||
| ROICexgc | 14.59% | ||
| OM | 8.57% | ||
| PM (TTM) | 7.85% | ||
| GM | 35.79% | ||
| FCFM | N/A |
ROA(3y)9.9%
ROA(5y)10.46%
ROE(3y)14.18%
ROE(5y)16.34%
ROIC(3y)9.49%
ROIC(5y)11.9%
ROICexc(3y)22.47%
ROICexc(5y)22.7%
ROICexgc(3y)23.46%
ROICexgc(5y)23.49%
ROCE(3y)12.88%
ROCE(5y)15.84%
ROICexgc growth 3Y-2.39%
ROICexgc growth 5Y-7.19%
ROICexc growth 3Y-4.58%
ROICexc growth 5Y-8.54%
OM growth 3Y6.9%
OM growth 5Y-6.46%
PM growth 3Y7.26%
PM growth 5Y-2.67%
GM growth 3Y9.69%
GM growth 5Y1.86%
F-Score4
Asset Turnover0.47
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.56 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 7.13 | ||
| Cap/Depr | 847.75% | ||
| Cap/Sales | 9.25% | ||
| Interest Coverage | 5.51 | ||
| Cash Conversion | 59.19% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.11 | ||
| Quick Ratio | 1.9 | ||
| Altman-Z | 2.83 |
F-Score4
WACC6.65%
ROIC/WACC0.58
Cap/Depr(3y)178.09%
Cap/Depr(5y)117.95%
Cap/Sales(3y)1.86%
Cap/Sales(5y)1.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-39.04%
EPS 3Y5.52%
EPS 5Y3.28%
EPS Q2Q%-105.22%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)13.42%
Revenue growth 3Y4.22%
Revenue growth 5Y2.9%
Sales Q2Q%-6.4%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-15.9%
EBIT growth 3Y11.4%
EBIT growth 5Y-3.75%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-118.58%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-70.18%
OCF growth 3YN/A
OCF growth 5YN/A
JIN MEDICAL INTERNATIONAL LT / ZJYL FAQ
Can you provide the ChartMill fundamental rating for JIN MEDICAL INTERNATIONAL LT?
ChartMill assigns a fundamental rating of 4 / 10 to ZJYL.
What is the valuation status for ZJYL stock?
ChartMill assigns a valuation rating of 2 / 10 to JIN MEDICAL INTERNATIONAL LT (ZJYL). This can be considered as Overvalued.
What is the profitability of ZJYL stock?
JIN MEDICAL INTERNATIONAL LT (ZJYL) has a profitability rating of 6 / 10.
Can you provide the financial health for ZJYL stock?
The financial health rating of JIN MEDICAL INTERNATIONAL LT (ZJYL) is 4 / 10.